NASDAQ
9.27USD
+0.01 (+0.11%)
We have scored 5 news catalysts on Adicet Bio, Inc. (ACET) over the past 12 months. The biggest single-day move next to one of them came Oct 7, 2025, when ACET closed −14.7%: “Adicet Bio, Inc. Announces $80 Million Registered Direct Offering”. Coverage across the window leans positive (average ticker sentiment +0.56). Most of the impact sits in short squeeze potential and earnings revision trend.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Latest scored catalyst for ACET: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market cap
86.7M
P/E
—
EPS
—
Beta
1.59
52W range
6.01-17.44
Day range
9.01–9.27
Open
9.15
Prev close
9.26
Volume
18.3K
Avg volume
95.5K
Dividend
0.00
IPO
2018-01-26
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the body's natural and acquired immune responses against cancer, and provide sustained therapeutic benefits for patients. ADI-001, its most advanced therapeutic candidate, is presently in a Phase I clinical trial for individuals with non-Hodgkin's lymphoma. Additionally, Adicet Bio is developing ADI-002, which is undergoing preclinical investigations for its potential in treating a range of solid tumors. The company is headquartered in Boston, Massachusetts.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Adicet Bio, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
